Poly Medicure Ltd (POLYMED) Q4FY25 Concall Summary - Mar-2025 Qtr
Performance Overview
- Poly Medicure Ltd. achieved consolidated revenue of Rs. 440 crores in Q4 FY25, representing a 16.5% YoY growth.
- Operating EBITDA reached Rs. 119.5 crores, up from Rs. 96.5 crores in Q4 FY24.
- EBITDA margin improved to 27.1% from 25.5%.
- PAT increased significantly to Rs. 91.8 crores from Rs. 68.4 crores.
- For the full fiscal year FY25, consolidated revenue grew by 21.5% to Rs. 1,670 crores, with EBITDA margins improving to 27.1% and PAT reaching Rs. 338.6 crores.
Financial Metrics
Log in to Stocksigma to read the Financial Metrics section of this summary.
Operating Performance / Business Segments
Log in to Stocksigma to read the Operating Performance / Business Segments section of this summary.
Key Discussions & Insights
Log in to Stocksigma to read the Key Discussions & Insights section of this summary.
Outlook and Guidance
Log in to Stocksigma to read the Outlook and Guidance section of this summary.
Challenges / Concerns
Log in to Stocksigma to read the Challenges / Concerns section of this summary.
Industry / Competitive Landscape
Log in to Stocksigma to read the Industry / Competitive Landscape section of this summary.
Overall Summary
Log in to Stocksigma to read the Overall Summary section of this summary.